GYPB and peptic ulcer disease: In the multivariable analysis (Table 3), malignancy (adjusted odds ratio [aOR] 2.78, 95% CI 1.33–5.91), single point increments in the Quick SOFA score (aOR 2.25, 95% CI 1.50–3.47), receiving immunosuppression within 30 days of blood culture draw (aOR 3.80, 95% CI, 1.86–8.01), and a history of peptic ulcer disease (aOR 5.63, 95% CI 1.43–21.0) were associated with an increased odds of speciating a pathogenic GPB.